On August 19, the American Academy of Pediatrics Committee on Infectious Diseases provided the following recommendations for Infants, Children, and Adolescents and COVID-19 Vaccines.
Infants and children 6-23 months of age who do not have contraindications should receive 2025-2026 COVID-19 vaccine
- Previously unvaccinated should receive initial series
- Previously vaccinated but incomplete should complete initial series
- Previously vaccinated and completed initial series should receive a single dose (8 weeks after last dose received)
- Previous asymptomatic infection or symptomatic disease should receive vaccination
Children 6 months – 18 years of age who are moderately or severely immunocompromised require 2+ doses of age-appropriate 2025-2026 COVID-19 vaccine depending on previous vaccination status
A single dose of age-appropriate 2025-2026 COVID-19 vaccine is recommended for all children and adolescents 2-18 years in the following high risk groups (regardless of prior COVID-19 vaccination status)
- At high risk of severe disease
- Residents of long-term care facilities or other congregate settings
- Persons who have never been vaccinated against COVID-19
- Persons whose household contacts are at high risk for severe COVID-19